Applied Operating Margin from 2010 to 2026
| APPB Stock | USD 0.0001 0.00 0.00% |
Check Applied Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Applied Biosciences' main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Interest Expense of 783.5 K or Selling General Administrative of 3.4 M, as well as many indicators such as Price To Sales Ratio of 33.78, Dividend Yield of 0.0 or Days Sales Outstanding of 48.26. Applied financial statements analysis is a perfect complement when working with Applied Biosciences Valuation or Volatility modules.
Applied | Operating Margin | Build AI portfolio with Applied Stock |
Analyzing Applied Biosciences's Operating Margin over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Operating Margin has evolved provides context for assessing Applied Biosciences's current valuation and future prospects.
Latest Applied Biosciences' Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of Applied Biosciences Corp over the last few years. It is Applied Biosciences' Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Applied Biosciences' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (5.72) % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
Applied Operating Margin Regression Statistics
| Arithmetic Mean | (8.46) | |
| Coefficient Of Variation | (33.96) | |
| Mean Deviation | 2.36 | |
| Median | (7.81) | |
| Standard Deviation | 2.87 | |
| Sample Variance | 8.25 | |
| Range | 8.2907 | |
| R-Value | 0.56 | |
| Mean Square Error | 6.01 | |
| R-Squared | 0.32 | |
| Significance | 0.02 | |
| Slope | 0.32 | |
| Total Sum of Squares | 132.01 |
Applied Operating Margin History
About Applied Biosciences Financial Statements
Applied Biosciences stakeholders use historical fundamental indicators, such as Applied Biosciences' Operating Margin, to determine how well the company is positioned to perform in the future. Although Applied Biosciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in Applied Biosciences' assets and liabilities are reflected in the revenues and expenses on Applied Biosciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Applied Biosciences Corp. Please read more on our technical analysis and fundamental analysis pages.
Applied Biosciences Corp. focuses on the development and commercialization of synthetic cannabinoid therapeuticsbiopharmaceuticals that target the endocannabinoid system to treat a range of diseases across various therapeutic areas. The company was incorporated in 2014 and is based in Beverly Hills, California. APPLIED BIOSCIENCES operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 25 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Applied Biosciences Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Applied Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Applied Biosciences Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Applied Biosciences Corp Stock:Check out the analysis of Applied Biosciences Correlation against competitors. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Applied Biosciences. If investors know Applied will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Applied Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
The market value of Applied Biosciences Corp is measured differently than its book value, which is the value of Applied that is recorded on the company's balance sheet. Investors also form their own opinion of Applied Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Applied Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Applied Biosciences' market value can be influenced by many factors that don't directly affect Applied Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Applied Biosciences' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Applied Biosciences represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Applied Biosciences' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.